학술논문

Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis.
Document Type
Article
Source
Archives of Rheumatology. Sep2020, Vol. 35 Issue 3, p440-442. 3p.
Subject
*ANTIRHEUMATIC agents
*NEUROTRANSMITTER uptake inhibitors
*PSORIASIS
*RHEUMATOID arthritis
*JANUS kinases
Language
ISSN
2148-5046
Abstract
Paradoxical psoriasis or psoriasiform lesion is an adverse effect, represented by the occurrence of a psoriasiform lesion or exacerbation of psoriasis caused by the drugs normally used for the management of psoriasis. In this article, we present the first case of a 45-year-old male patient with rheumatoid arthritis who developed psoriasiform lesions following treatment with tofacitinib, and highlight the possible pathogenetic mechanisms involved in such an occurrence. [ABSTRACT FROM AUTHOR]